Richard Newitter analyst TRUIST

Currently out of the existing stock ratings of Richard Newitter, 334 are a BUY (57.29%), 247 are a HOLD (42.37%), 2 are a SELL (0.34%).

Richard Newitter

Work Performance Price Targets & Ratings Chart

Analyst Richard Newitter, currently employed at TRUIST, carries an average stock price target met ratio of 61.56% that have a potential upside of 22.69% achieved within 201 days.

Richard Newitter’s has documented 1,166 price targets and ratings displayed on 38 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ITGR, Integer Holdings Corp at 20-Feb-2026.

Wall Street Analyst Richard Newitter

Analyst best performing recommendations are on SIEN (SIENTRA).
The best stock recommendation documented was for INSP (INSPIRE MEDICAL SYSTEMS) at 11/24/2025. The price target of $128 was fulfilled within 1 day with a profit of $10.71 (9.13%) receiving and performance score of 91.31.

Average potential price target upside

ALC Alcon AG ALGN Align Technology AXGN Axogen BDX Becton Dickinson and Company GMED Globus Medical HOLX Hologic INSP Inspire Medical Systems ISRG Intuitive Surgical ITMR Itamar Medical Ltd LNTH Lantheus Holdings NUVA NuVasive SIEN Sientra SYK Stryker TFX Teleflex XENT Intersect ENT ZBH Zimmer Biomet Holdings AXNX Axonics Modulation Technologies CNMD CONMED IART Integra LifeSciences Holdings MDT Medtronic PLC WMGI Wright Medical Group N.V EW Edwards Lifesciences Corp NARI Inari Medical  SPNE SeaSpine Holdings Corp BSX Boston Scientific Corp KIDS Orthopediatrics Corp NVRO Nevro Corp PRCT Procept Biorobotics Corp TMCI Treace Medical Concepts IRTC iRhythm Technologies GKOS Glaukos Corp IRT Independence Realty Trust ITGR Integer Holdings Corp PEN Penumbra VCEL Vericel Corp Ord DXCM DexCom PODD Insulet TNDM Tandem Diabetes Care

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 09-Jan-2026

$80

$-2.63 (-3.18%)

$85

1 months 15 days ago
(09-Jan-2026)

5/6 (83.33%)

$-0.13 (-0.16%)

96

Buy Since 19-Aug-2021

$91

$8.37 (10.13%)

$91

3 months ago
(24-Nov-2025)

8/12 (66.67%)

$14.75 (19.34%)

110

Buy Since 10-May-2023

$98

$15.37 (18.60%)

$95

3 months 11 days ago
(13-Nov-2025)

7/12 (58.33%)

$19.39 (24.67%)

285

Buy Since 08-Apr-2022

$98

$15.37 (18.60%)

$107

3 months 12 days ago
(12-Nov-2025)

15/28 (53.57%)

$18.56 (23.36%)

396

Buy Since 15-Apr-2019

$100

$17.37 (21.02%)

$110

3 months 13 days ago
(11-Nov-2025)

8/12 (66.67%)

$22.64 (29.27%)

338

Show more analysts

Please expand the browser size to see the chart

Which stock is Richard Newitter is most bullish on?

Potential upside of $145.95 has been obtained for ISRG (INTUITIVE SURGICAL)

Which stock is Richard Newitter is most reserved on?

Potential downside of $1.11 has been obtained for TMCI (TREACE MEDICAL CONCEPTS)

What Year was the first public recommendation made by Richard Newitter?

On 2008

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?